Literature DB >> 2141575

'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.

F Märki1, J Pfeilschifter, H Rink, I Wiesenberg.   

Abstract

The 'antiflammin' nonapeptides P1 and P2 [(1988) Nature 335, 726-730] were synthesized and tested for inhibition of phospholipase A2 and release of prostaglandin E2 and leukotriene C4 in stimulated cells in vitro, and in vivo for anti-inflammatory activity in rats with carrageenan-induced paw oedema. Porcine pancreatic phospholipase A2 was not inhibited at concentrations of 0.5-50 microM. Prostaglandin E2 and leukotriene C4 release by mouse macrophages stimulated with zymosan or ATP was not affected up to a concentration of 10 microM, nor was prostaglandin release by interleukin 1 beta-stimulated mesangial cells and angiotensin II-stimulated smooth muscle cells. Both peptides exhibited no anti-inflammatory activity in carrageenan-induced rat paw oedema after topical (250 micrograms/paw) or systemic administration (1 or 4 mg/kg s.c.). These results do not support the claim of potent phospholipase A2-inhibitory and anti-inflammatory activity of the 'antiflammins' P1 and P2.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2141575     DOI: 10.1016/0014-5793(90)80241-a

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Uptake and accumulation of tritiated uteroglobin by day-6 rabbit blastocysts.

Authors:  D R Dannhorn; C Kirchner
Journal:  Cell Tissue Res       Date:  1990-12       Impact factor: 5.249

Review 2.  Annexins: calcium-binding proteins of multi-functional importance?

Authors:  J Römisch; E P Pâques
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

3.  Oxidative degradation of antiflammin 2.

Authors:  J M Ye; J L Wolfe
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

4.  Uteroglobin in the developing rabbit conceptus in vivo and in vitro.

Authors:  D R Dannhorn; S Gierhake; C Kirchner
Journal:  Anat Embryol (Berl)       Date:  1991

5.  Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities.

Authors:  W C Hope; B J Patel; D R Bolin
Journal:  Agents Actions       Date:  1991-09

6.  A novel anti-inflammatory peptide from human lipocortin 5.

Authors:  M Perretti; C Becherucci; K G Mugridge; E Solito; S Silvestri; L Parente
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

7.  Uteroglobin, a possible ligand of the lipoxin receptor inhibits serum amyloid A-driven inflammation.

Authors:  Giovanni Antico; Monica Aloman; Katja Lakota; Lucio Miele; Stefano Fiore; Snezna Sodin-Semrl
Journal:  Mediators Inflamm       Date:  2014-03-23       Impact factor: 4.711

8.  Antiflammin-2 activates the human formyl-peptide receptor like 1.

Authors:  Ahmad M Kamal; Richard P G Hayhoe; Anbalakan Paramasivam; Dianne Cooper; Roderick J Flower; Egle Solito; Mauro Perretti
Journal:  ScientificWorldJournal       Date:  2006-10-25

9.  Selective inhibition by antiflamrnin-2 of thromboxane B(2) release from isolated and perfused guinea-pig lung.

Authors:  L Sautebin; G Cirino; M D Rosa
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.